Tag: WTO
News alerts
Latest content
- Study highlights advance in influenza protection for older adults

- NICE backs daratumumab quadruplet for transplant‑eligible myeloma

- Teitur reports positive early data for Parkinson’s peptide TT‑P34

- Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer

- NICE backs ibrutinib regimen for untreated mantle cell lymphoma

Contact details
PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
